PTCT compared with GMED: revenue, margins and what each company keeps, and the suppliers and customers both name

PTCTPTC Therapeutics, Inc.

Mkt capRevenueRevenue

GMEDGlobus Medical Inc

Mkt capRevenueRevenue

Compare

PTCTPTC Therapeutics, Inc.

GMEDGlobus Medical Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

PTCT

1 of 4at or beyond implied

Reportimpliedrealized× implied

Oct 30 '26±12.0%▼−6.97%×0.58

Q2 FY26±11.6%▼−9.94%×0.85

Q1 FY26±9.4%▲+14.27%×1.52

Feb 20 '26±4.3%▲+1.09%×0.26

GMED2 of 4 reports

1 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±9.8%▼−12.76%×1.31

Q2 FY26—▲+1.57%—

= impliedPTCT realized, solidGMED realized, hatchedOne scale, both sides: full bar = 15%× = |realized| ÷ impliedspan: PTCT 252d · GMED 91dSource: market data

PTCTPTC Therapeutics, Inc.

65.49▼−0.27%· post 65.50

Mkt cap$5.5BRevenue$361MQ2 FY26Revenue$1.7BFY25

GMEDGlobus Medical Inc

70.94▼−12.89%· post 71.30

ClosedNov 6 '26

Mkt cap$9.4BRevenue$764MQ3 FY26Revenue$2.9BFY25

Compare

ClosedNov 6 '26

PTCTPTC Therapeutics, Inc.

GMEDGlobus Medical Inc

65.49▼−0.27%post 65.50

Price

70.94▼−12.89%post 71.30

$5.5B

Mkt cap

$9.4B

Q2 FY26$361M

Revenue

$764MQ3 FY26

FY25$1.7B

Revenue

$2.9BFY25

PTCT65.49▼−0.27%vsGMED70.94▼−12.89%ClosedNov 6 '26